Sinemet CR

In the US, Sinemet CR (carbidopa/levodopa systemic) is a member of the drug class dopaminergic antiparkinsonism agents and is used to treat GTP-CH Deficiency, Neuroleptic Malignant Syndrome, Parkinson's Disease and Restless Legs Syndrome.

US matches:

• Sinemet CR Sustained-Release Tablets


• Sinemet CR

Ingredient matches for Sinemet CR

Carbidopa

Carbidopa is reported as an ingredient of Sinemet CR in the following countries:

• Chile


• China


• Israel


• Lithuania


• New Zealand


• Peru


• Romania


• Switzerland

Carbidopa monohydrate (a derivative of Carbidopa) is reported as an ingredient of Sinemet CR in the following countries:

• Croatia (Hrvatska)

Levodopa

Levodopa is reported as an ingredient of Sinemet CR in the following countries:

• Chile


• China


• Croatia (Hrvatska)


• Israel


• Lithuania


• New Zealand


• Peru


• Romania


• Switzerland

International Drug Name Search